Search
for
Sort by
Research 121–150 of 170
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- Epigenetics of Colorectal Cancer
- JMJD3 and NF-κB-dependent activation of Notch1 gene is required for keratinocyte migration during skin wound healing
- SARS-CoV-2 Non-Structural Proteins and Their Roles in Host Immune Evasion
- Epidermal Differentiation Complex: A Review on Its Epigenetic Regulation and Potential Drug Targets.
- Birt–Hogg–Dubé syndrome: from gene discovery to molecularly targeted therapies
- Targeting Wnt Signaling for Gastrointestinal Cancer Therapy: Present and Evolving Views
- Recent advances on skin‐resident stem/progenitor cell functions in skin regeneration, aging and cancers and novel anti‐aging and cancer therapies
- FOXP3 <sup>+</sup> regulatory T cells and age‐related diseases
- Exploring the relationship between anastasis and mitochondrial ROS-mediated ferroptosis in metastatic chemoresistant cancers: a call for investigation
- Merkel cell carcinoma: updates in tumor biology, emerging therapies, and preclinical models
- Induced pluripotent stem cells: Generation methods and a new perspective in COVID-19 research
- Class IIa HDAC4 and HDAC7 cooperatively regulate gene transcription in Th17 cell differentiation
- Copper Modulates Mitochondrial Oxidative Phosphorylation to Enhance Dermal Papilla Cells Proliferation in Rex Rabbits
- Molecular Targeted Agents and Biologic Therapies for Non-small Cell Lung Cancer
- Isoxazole 9 (ISX9), a small molecule targeting Axin, activates Wnt/β‐catenin signalling and promotes hair regrowth
- Androgens in cervical cancer: Their role in epidemiology and biology
- Genome-wide p63-Target Gene Analyses Reveal TAp63/NRF2-Dependent Oxidative Stress Responses
- Stimuli-responsive nanoformulations for CRISPR-Cas9 genome editing
- Cellular and Molecular Mechanisms of Wound Repair: From Biology to Therapeutic Innovation
- Selection signatures for fiber production in commercial species: A review
- Orchestration of tissue‐scale mechanics and fate decisions by polarity signalling
- Targeting the (Un)differentiated State of Cancer
- HSP90 Inhibition and Cellular Stress Elicits Phenotypic Plasticity in Hematopoietic Differentiation
- Advancing Design Strategy of PROTACs for Cancer Therapy
- Gut microbiome, metabolome and alopecia areata
- Cold Atmospheric Plasma for Breast Cancer
- Fibroblast Lineage Switching as the Developmental Origin of Scarring and Target for Regenerative Healing
- Immunosenescence and inflammaging in Parkinson’s disease: mechanisms and therapeutic prospects
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology